P3.01-115 Liposomal Paclitaxel Versus Gemcitabine: Which Is Better?

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.1676
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Performance Status Dynamics During Treatment With Nab-Paclitaxel Plus Gemcitabine Versus Gemcitabine Alone for Metastatic Pancreatic Cancer

Cancer Management and Research
Oncology
2018English

Manual Vacuum Aspiration Versus Sharp Curettage for Incomplete Abortion: Which One Is Better?

Indonesian Journal of Obstetrics and Gynecology
2019English

Neoadjuvant Treatment With Gemcitabine Plus Nab-Paclitaxel Versus Surgery First for Pancreatic Adenocarcinoma

HPB
HepatologyGastroenterology
2018English

ACE Inhibition Versus Angiotensin Receptor Blockade: Which Is Better for Renal and Cardiovascular Protection?

Journal of the American Society of Nephrology : JASN
MedicineNephrology
2004English

Control of Cystic Artery During Laparoscopic Cholecystectomy: Clips Versus Ultrasonic Energy Devices Which Is Better?

International Surgery Journal
2017English

P3.01-97 Which Is Better Prognostic Factor, PS, Inflammatory Marker, or PD-L1 Expression in Treating NSCLC With Nivolmab; A Retrospective Analysis

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Which Is Better Stainless Steel or Titanium Alloy?

Turkish Neurosurgery
SurgeryNeurology
2017English

Ensemble and Multiple Kernel Regressors: Which Is Better?

IEICE Transactions on Fundamentals of Electronics, Communications and Computer Sciences
Electronic EngineeringComputer GraphicsSignal ProcessingApplied MathematicsElectricalComputer-Aided Design
2015English

Placebo Versus Best-Available-Therapy Control Group in Clinical Trials for Pharmacologic Therapies: Which Is Better?

Proceedings of the American Thoracic Society
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy